DK0947513T3 - Tricykliske aminderivater - Google Patents

Tricykliske aminderivater

Info

Publication number
DK0947513T3
DK0947513T3 DK97909605T DK97909605T DK0947513T3 DK 0947513 T3 DK0947513 T3 DK 0947513T3 DK 97909605 T DK97909605 T DK 97909605T DK 97909605 T DK97909605 T DK 97909605T DK 0947513 T3 DK0947513 T3 DK 0947513T3
Authority
DK
Denmark
Prior art keywords
hydrate
chem
tricyclic amine
salt
compound
Prior art date
Application number
DK97909605T
Other languages
English (en)
Inventor
Makoto Takemura
Hisashi Takahashi
Kenichi Kimura
Rie Miyauchi
Hitoshi Ohki
Katsuhiro Kawakami
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0947513T3 publication Critical patent/DK0947513T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97909605T 1996-10-25 1997-10-23 Tricykliske aminderivater DK0947513T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28344696 1996-10-25
JP9125497 1997-04-10

Publications (1)

Publication Number Publication Date
DK0947513T3 true DK0947513T3 (da) 2004-08-30

Family

ID=26432708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97909605T DK0947513T3 (da) 1996-10-25 1997-10-23 Tricykliske aminderivater

Country Status (12)

Country Link
US (2) US6384050B1 (da)
EP (1) EP0947513B1 (da)
KR (1) KR100531967B1 (da)
CN (1) CN1103769C (da)
AT (1) ATE267191T1 (da)
AU (1) AU4723197A (da)
DE (1) DE69729213T2 (da)
DK (1) DK0947513T3 (da)
ES (1) ES2221040T3 (da)
PT (1) PT947513E (da)
TW (1) TW491849B (da)
WO (1) WO1998018783A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812644B1 (pt) 1997-09-15 2010-07-13 quinolonas antimicrobianas, composição farmacêutica e uso das mesmas.
EP1161956A4 (en) 1999-03-17 2005-03-16 Daiichi Seiyaku Co DRUG COMPOSITIONS
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2002048143A2 (en) 2000-12-14 2002-06-20 The Procter & Gamble Company Antimicrobial 2-pyridones, their compositions and uses
BR0116217A (pt) 2000-12-14 2003-12-30 Procter & Gamble Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
DE60228330D1 (de) * 2001-12-19 2008-09-25 Bristol Myers Squibb Co Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren
ATE507219T1 (de) 2006-03-28 2011-05-15 Warner Chilcott Co Llc Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure
EP1999125A2 (en) 2006-03-28 2008-12-10 The Procter and Gamble Company A coupling process for preparing quinolone intermediates
EP1849770A1 (en) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Production process for bicyclic tetrahydropyrrole compounds
CN102140098A (zh) * 2010-01-29 2011-08-03 南京医科大学 7-(2-取代-3-氨基-1-四氢吡咯[3,4-c]吡唑基)喹啉羧酸衍生物及其制备方法和在抗菌抗结核上的应用
US10435389B2 (en) * 2017-09-11 2019-10-08 Krouzon Pharmaccuticals, Inc. Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637886A (en) 1982-12-27 1987-01-20 Exxon Research & Engineering Co. Macrocyclic polyamine and polycyclic polyamine multifunctional lubricating oil additives
JPH0676400B2 (ja) * 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
HU219403B (hu) 1989-08-16 2001-04-28 Pfizer Inc. Azabiciklo-csoporttal helyettesített kinolon- és naftiridon-karbonsavak és eljárás ezek előállítására
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
US6586604B2 (en) 2003-07-01
KR100531967B1 (ko) 2005-11-30
CN1103769C (zh) 2003-03-26
US20010037030A1 (en) 2001-11-01
KR20000052784A (ko) 2000-08-25
ATE267191T1 (de) 2004-06-15
US6384050B1 (en) 2002-05-07
DE69729213D1 (de) 2004-06-24
WO1998018783A1 (fr) 1998-05-07
EP0947513B1 (en) 2004-05-19
EP0947513A4 (en) 2002-10-02
ES2221040T3 (es) 2004-12-16
PT947513E (pt) 2004-09-30
DE69729213T2 (de) 2005-05-04
TW491849B (en) 2002-06-21
CN1242011A (zh) 2000-01-19
EP0947513A1 (en) 1999-10-06
AU4723197A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
NO950297L (no) Prolinamidderivater
DE69331414T2 (de) Depsipeptide, herstellung und anwendung
PT1319651E (pt) Composto 2-aminopropano-1,3-diol, sua utilizacao farmaceutica e seus intermediarios sinteticos
ATE267191T1 (de) Tricyclische aminderivate
PT718293E (pt) Composto ciclodepsipeptidico
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
MX9206093A (es) Derivado de oxazolidona
ATE126796T1 (de) Quinazolinderivate und ihre herstellung.
DE68919378T2 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
BR9916466A (pt) Compostos de organofósforo e seu uso
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
MX9206930A (es) Nuevos compuestos
DE69400352T2 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids
PT816355E (pt) Derivados espiro-heterociclicos
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.